Comparison of 2,17-dimethyl testosterone and fluoxymesterone in metastatic breast cancer. Nonprogression--an index of tumor therapy evaluation.

TALLEY, R W

Comparison of 2,17-dimethyl testosterone and fluoxymesterone in metastatic breast cancer. Nonprogression--an index of tumor therapy evaluation. [electronic resource] - Cancer Apr 1963 - 440-3 p. digital

Publication Type: Journal Article

0008-543X

10.1002/1097-0142(196304)16:4<440::aid-cncr2820160404>3.0.co;2-g doi


Anatomy
Antineoplastic Agents
Breast Neoplasms
Fluoxymesterone
Humans
Methyltestosterone